Last reviewed · How we verify
NCT03904290: PFO CLOSE
Does Patent Foramen Ovale Closure Improve Exercise Capacity & Prevent Blood Flow Through Intrapulmonary Shunt
NA trial testing PFO Closure in Patent Foramen Ovale in 10 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | University of Oregon |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 5 April 2018 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PFO Closure
Conditions studied
- Patent Foramen Ovale — all drugs for Patent Foramen Ovale →
Sponsor
University of Oregon
Who can join
Adults 18 to 80, any sex, with Patent Foramen Ovale. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching goal of this study is to examine cardiopulmonary and respiratory physiology pre and post PFO/ASD closure in patients who are undergoing surgical closure of their PFO/ASD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03904290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patent Foramen Ovale
Currently open trials in the same condition.
- NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
- NCT05907694 — Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure · NA · recruiting
- NCT06953622 — Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale · recruiting
- NCT06156670 — Russian Registry of Endovascular Closure of PFO · recruiting
- NCT05387954 — PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years · Phase 3 · recruiting
Other University of Oregon trials
Trials by the same sponsor.
- NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
- NCT07471633 — Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions · NA · not yet recruiting
- NCT07264621 — The University of Oregon ACCESS Project · NA · enrolling by invitation
- NCT07025083 — Adaptation of the Family Check-Up Online · NA · recruiting
- NCT06843200 — Conversations With Caregivers About Health and Appearance · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03904290 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oregon
- Last refreshed: 1 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03904290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing